Le Lézard
Classified in: Health
Subject: RCL

Food Recall Warning - Louis Latour brand Pinot Noir recalled due to possible presence of glass


Product photo is available:  https://recalls-rappels.canada.ca/en/alert-recall/louis-latour-brand-pinot-noir-recalled-due-possible-presence-glass

OTTAWA, ON, Feb. 18, 2023 /CNW/ -

Summary
Affected products

Brand

Product                       

Size

UPC                      

Codes        

Louis Latour   

Pinot Noir Bourgogne
2021

375 mL   

3 566922 002975

L2217977
L2221076
L2221065
L2221077

 

Issue

The affected product is being recalled from the marketplace due to the possible presence of glass.

The recalled product has been sold in Ontario.

What you should do

Learn more:

Background

This recall was triggered by a recall in another country.

There have been no reported injuries associated with the consumption of this product.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products.

The CFIA is verifying that industry is removing recalled products from the marketplace.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 07:50
Tilray Brands, Inc. ("Tilray Brands" or the "Company") , a leading global lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, announced today that it has filed a prospectus...

at 07:30
The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, will host its VISIONS 2024 conference at the Chicago Marriott Downtown Magnificent Mile on June 21?22, 2024. This biennial...

at 07:30
Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new groundbreaking algorithm, SignalHF1, used...

at 07:30
The American Trucking Associations is calling attention to the negative consequences for highway safety and safety-sensitive industries that could result from the U.S. Drug Enforcement Administration's proposal to reschedule marijuana from a Schedule...

at 07:30
-    AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)-    Data to be presented from...

at 07:28
We are advised by OsteoStrong that journalists and other readers should disregard the news release, OsteoStrong Celebrates Success and Innovation at 11th Annual Global Franchise Owner Convention, issued May 9, 2024 over PR Newswire. SOURCE...



News published on and distributed by: